Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet - DGFT - 46/2024-25

Government of India Ministry of Commerce Industry Department of Commerce Directorate General of Foreign Trade Public Notice No. 46/2024-25 New Delhi, Dated 6 th February, 2025 Subject: Amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet. In exercise of the powers conferred under paragraphs 1.03 and 2.04 of the Foreign Trade Policy-2023 as amended from time to time, the Director General of Foreign Trade makes the following amendments in Standard Input Output Norms (SION) A-222 for export of Erythromycin Stearate Tablet. Export Product Quantity Sl. No. Import Item/s Quantity Erythromycin Stearate tablets-250 mg. (each tablet contains erythromycin stearate equivalent to 250 mg. of Erythromycin 1 Number Tablet 1 Erythromycin Stearate 334 mg. Note: For other variants of export items, norms may be worked out on a pro-rata basis. Effect of the Public Notice : Standard Input Output Norm appearing under A-222 is amended as above with immediate effect. (Santosh Kumar Sarangi) Director General of Foreign Trade Ex-officio Addl. Secretary to the Government of India e-mail: [email protected] (Issued from File No. 01/82/0017/AM-25/DES-III)